Maitreya Medicare Ltd vs Tarsons Products Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Maitreya Medicare Ltd is ₹ 144.55 as of 23 Oct 15:30 . The P/E Ratio of Maitreya Medicare Ltd changed from 30.8 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Tarsons Products Ltd changed from 37.2 on March 2022 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years The Market Cap of Maitreya Medicare Ltd changed from ₹ 80.63 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Tarsons Products Ltd changed from ₹ 3746 crore on March 2022 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years The revenue of Maitreya Medicare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tarsons Products Ltd for the Jun '26 is ₹ 116.22 crore as compare to the Mar '26 revenue of ₹ 127.76 crore. This represent the decline of -9.03% The ebitda of Maitreya Medicare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tarsons Products Ltd for the Jun '26 is ₹ 31.96 crore as compare to the Mar '26 ebitda of ₹ 41.1 crore. This represent the decline of -22.24% The net profit of Maitreya Medicare Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Tarsons Products Ltd changed from ₹ 4.02 crore to ₹ -1.44 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Maitreya Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Tarsons Products Ltd changed from 20.76 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 years .

About Maitreya Medicare Ltd

Maitreya Medicare Limited was originally incorporated as Maitreya Medicare Private Limited' at Surat Gujarat, vide a Certificate of Incorporation dated March 28, 2019, issued by the Registrar of Companies, Central Registration Centre (CRC).
Thereafter, name of the Company was changed to Maitreya Medicare Limited' and a fresh Certificate of Incorporation was issued by the RoC on March 30, 2023.
Since then, Company engages in providing healthcare services and products. The Company was founded by Dr. Narendra Singh Tanwar, an eminent and highly skilled cardiologist who has more than 20 years of experience in healthcare industry.
The Company is a growing organization that aims at strengthening and establishing itself as foremost healthcare services provider.
It has a team of medical practitioners who ensures that patients get the quality healthcare services.

About Tarsons Products Ltd

Tarsons Products Limited was incorporated as Tarsons Products Private Limited on July 5, 1983.
The Company was subsequently converted into a Public Limited Company and the name of the Company was changed to Tarsons Products Limited on June 14, 2021. Tarsons is an Indian labware Company engaged in designing, developing, manufacturing and marketing of consumables', reusables' and others' (including benchtop equipment), used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies and hospitals.
The Company is also engaged in the manufacturing of wide range of quality labware products which helps scientific discovery and improve healthcare.
Tarsons currently operate through five manufacturing facilities located in West Bengal.

FAQs for the comparison of Maitreya Medicare Ltd and Tarsons Products Ltd

Which company has a larger market capitalization, Maitreya Medicare Ltd or Tarsons Products Ltd?

Market cap of Maitreya Medicare Ltd is 97 Cr while Market cap of Tarsons Products Ltd is 1,595 Cr

What are the key factors driving the stock performance of Maitreya Medicare Ltd and Tarsons Products Ltd?

The stock performance of Maitreya Medicare Ltd and Tarsons Products Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Maitreya Medicare Ltd and Tarsons Products Ltd?

As of October 25, 2026, the Maitreya Medicare Ltd stock price is INR ₹144.55. On the other hand, Tarsons Products Ltd stock price is INR ₹299.95.

How do dividend payouts of Maitreya Medicare Ltd and Tarsons Products Ltd compare?

To compare the dividend payouts of Maitreya Medicare Ltd and Tarsons Products Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.